Mainz Biomed NV
MYNZ1.420USD
+0.090+6.77%
Close 08/04, 16:00（ET）Quotes delayed by 15 min
1.420USD+1.420After-hours (ET)
3.29MMarket Cap
LossP/E TTM
Mainz Biomed NV
1.420
+0.090+6.77%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2024H2
FY2024H1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022H2
FY2022H1
Operating cash flows (indirect method)
Cash flow from continuing operating activities
---8.95M
---8.14M
---4.66M
---6.51M
---5.12M
---5.66M
---8.31M
---6.46M
Net income from continuing operations
---10.63M
---11.02M
---5.18M
---6.30M
---8.25M
---6.56M
---13.78M
---12.60M
Operating gains losses
--520.09K
--496.95K
--204.47K
--203.57K
--171.02K
--287.35K
--317.43K
--62.37K
Other non-cash items
--1.74M
--692.74K
---730.40K
--182.81K
--4.75K
--92.30K
---14.38K
--41.17K
Change in working capital
---609.20K
--660.95K
--235.08K
---1.68M
--1.78M
---397.55K
--1.03M
--359.94K
-Change in receivables
--129.23K
---64.95K
--101.23K
---144.59K
--31.24K
--27.66K
---163.86K
---47.37K
-Change in inventory
--21.54K
--8.27K
---158.13K
---133.69K
---121.05K
---87.31K
---134.11K
---38.27K
-Change in prepaid expenses
---441.89K
--450.66K
---132.18K
---479.55K
--318.44K
--53.58K
---385.87K
--332.08K
-Change in payables and accrued expense
---200.55K
--285.16K
--484.67K
---925.95K
--1.55M
---390.17K
--1.71M
--113.50K
-Change in other current liabilities
---117.53K
---18.20K
---60.52K
--1.33K
---21.00
---1.31K
----
----
Cash from non-recurring investing activities
Cash from operating activities
---8.95M
---8.14M
---4.66M
---6.51M
---5.12M
---5.66M
---8.31M
---6.46M
Investing cash flow
Net cash from continuing investing activities
---189.06K
--420.66K
--261.81K
--112.48K
--123.63K
--1.40M
--406.04K
--252.45K
Capital expenditures
----
--420.66K
--261.81K
--112.48K
--123.63K
--1.40M
--406.04K
--252.45K
Net cash flow from disposal of fixed assets
---39.06K
--120.66K
--161.81K
--12.48K
--123.63K
--900.93K
--406.04K
--252.45K
Net cash flow from intangible asset transactions
---150.00K
--300.00K
--100.00K
--100.00K
--0.00
--500.00K
----
----
Net cash flow from business transactions
--32.78K
----
----
----
----
----
----
----
Cash from non-current investing activities
Net cash flow from investing activities
--221.84K
---420.66K
---261.81K
---112.48K
---123.63K
---1.40M
---406.04K
---252.45K
Financing cash flow
Cash flow from continuous financing activities
--14.05M
--2.55M
--3.47M
--4.57M
--5.42M
--773.48K
---148.23K
--24.09M
Net cash flow from debt Issuance/repayment
--798.85K
--2.04M
---1.03M
--5.50M
--4.39M
---91.28K
---148.23K
---156.74K
Net cash flow from common stock issuance/repurchase
--13.25M
--515.26K
--4.50M
---1.55K
--611.36K
--1.28M
----
--23.87M
Proceeds from issuance of warrants
----
----
----
--0.00
--0.00
--0.00
--0.00
--382.50K
Net cash flow from other financing activities
----
----
--1.12K
---934.87K
--418.63K
---418.63K
---1.00
----
Net cash from non-recurrent financing activities
Net cash from financing activities
--14.05M
--2.55M
--3.47M
--4.57M
--5.42M
--773.48K
---148.23K
--24.09M
Net cash flow
Beginning cash balance
--977.76K
--7.07M
--9.32M
--10.91M
--10.86M
--17.14M
--26.01M
--8.73M
Current period cash flow changes
--5.26M
---6.09M
---2.25M
---1.59M
--52.88K
---6.28M
---8.86M
--17.28M
Effect of exchange rate changes
---66.97K
---79.08K
---798.27K
--458.93K
---123.78K
--3.26K
--2.12K
---103.23K
Ending cash balance
--6.24M
--977.76K
--7.07M
--9.32M
--10.91M
--10.86M
--17.14M
--26.01M
Free cash flow
---8.95M
---8.57M
---4.92M
---6.62M
---5.24M
---7.06M
---8.72M
---6.71M
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
